We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Icelandic generic company Actavis plans to buy Romanian generic drugmaker Sindan for $177 million cash, the latest in a string of acquisitions for Actavis.